Ibrance 75 mg

Ibrance 75 mg is a medicine authorised by Swissmedic under authorisation number 69183. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 06 September 2023 and the authorisation is limited until 05 September 2028. ATC code L01EF01 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 69183
  • ATC L01EF01
  • Synthetic medicines
Authorisation data
Authorisation number69183
NameIbrance 75 mg
Full nameIbrance 75 mg, Filmtabletten
Authorisation holderPfizer AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01EF01
First authorisation06 September 2023
Authorisation validity05 September 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Ibrance 75 mg, FilmtablettenA06 September 2023
2Ibrance 100 mg, FilmtablettenA06 September 2023
3Ibrance 125 mg, FilmtablettenA06 September 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
121Tablette(n)L01EF0107.16.1.A
221Tablette(n)L01EF0107.16.1.A
321Tablette(n)L01EF0107.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ibrance 75 mg authorised in Switzerland?

Yes. Ibrance 75 mg is authorised by Swissmedic under authorisation number 69183, data as of 01 September 2026. The authorisation is limited until 05 September 2028.

Which dispensing category does Ibrance 75 mg have?

Ibrance 75 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Ibrance 75 mg?

The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com